Benjamin F. Edwards & Company’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$5.02M Buy
34,464
+7,342
+27% +$1.05M 0.09% 220
2024
Q1
$4.01M Buy
27,122
+612
+2% +$87.8K 0.07% 241
2023
Q4
$3.62M Buy
26,510
+10,596
+67% +$1.38M 0.07% 239
2023
Q3
$2.05M Buy
15,914
+907
+6% +$120K 0.08% 240
2023
Q2
$1.99M Sell
15,007
-389
-3% -$51.3K 0.08% 241
2023
Q1
$1.99M Sell
15,396
-63,293
-80% -$8.27M 0.08% 227
2022
Q4
$10.7M Buy
78,689
+10,410
+15% +$1.38M 0.48% 48
2022
Q3
$8.27M Buy
68,279
+4,125
+6% +$531K 0.41% 61
2022
Q2
$8.23M Sell
64,154
-15,956
-20% -$2.09M 0.4% 63
2022
Q1
$11M Buy
80,110
+56,214
+235% +$7.44M 0.49% 49
2021
Q4
$3.37M Sell
23,896
-3,302
-12% -$438K 0.15% 154
2021
Q3
$3.46M Buy
27,198
+1,132
+4% +$150K 0.17% 134
2021
Q2
$3.28M Sell
26,066
-2,788
-10% -$342K 0.17% 141
2021
Q1
$3.37M Sell
28,854
-1,551
-5% -$179K 0.18% 134
2020
Q4
$3.45M Sell
30,405
-2,755
-8% -$301K 0.2% 122
2020
Q3
$3.5M Buy
33,160
+20,953
+172% +$2.21M 0.23% 106
2020
Q2
$1.22M Sell
12,207
-56,164
-82% -$5.54M 0.09% 231
2020
Q1
$6.06M Sell
68,371
-36,752
-35% -$3.57M 0.52% 44
2019
Q4
$10.7M Buy
105,123
+73,219
+229% +$7.04M 0.75% 21
2019
Q3
$2.88M Buy
31,904
+5,277
+20% +$482K 0.22% 112
2019
Q2
$2.47M Sell
26,627
-30,744
-54% -$2.76M 0.21% 121
2019
Q1
$5.26M Buy
57,371
+45,522
+384% +$4.1M 0.48% 41
2018
Q4
$1.02M Sell
11,849
-19,502
-62% -$1.77M 0.11% 202
2018
Q3
$2.98M Buy
31,351
+19,638
+168% +$1.77M 0.28% 85
2018
Q2
$978K Buy
11,713
+804
+7% +$66.6K 0.1% 223
2018
Q1
$888K Sell
10,909
-161,644
-94% -$13.8M 0.09% 231
2017
Q4
$14.3M Buy
172,553
+5,615
+3% +$463K 1.49% 7
2017
Q3
$13.6M Sell
166,938
-7,115
-4% -$571K 1.64% 7
2017
Q2
$13.8M Buy
174,053
+3,853
+2% +$294K 1.8% 7
2017
Q1
$12.7M Buy
170,200
+61,557
+57% +$4.49M 1.86% 6
2016
Q4
$7.49M Buy
108,643
+32,215
+42% +$2.24M 1.23% 17
2016
Q3
$5.51M Buy
76,428
+13,001
+20% +$957K 0.97% 23
2016
Q2
$4.55M Buy
63,427
+10,044
+19% +$708K 0.89% 24
2016
Q1
$3.62M Sell
53,383
-9,006
-14% -$603K 0.75% 34
2015
Q4
$4.49M Sell
62,389
-25,672
-29% -$1.81M 0.97% 24
2015
Q3
$5.83M Sell
88,061
-2,371
-3% -$173K 1.28% 11
2015
Q2
$6.73M Buy
90,432
+4,057
+5% +$301K 1.34% 12
2015
Q1
$6.26M Sell
86,375
-6,137
-7% -$438K 1.31% 10
2014
Q4
$6.33M Buy
92,512
+24,209
+35% +$1.62M 1.47% 10
2014
Q3
$4.37M Sell
68,303
-7,176
-10% -$449K 1.09% 14
2014
Q2
$4.59M Buy
75,479
+23,002
+44% +$1.35M 1.17% 13
2014
Q1
$3.07M Buy
52,477
+6,733
+15% +$388K 0.84% 20
2013
Q4
$2.54M Sell
45,744
-29,659
-39% -$1.59M 0.86% 24
2013
Q3
$3.81M Buy
75,403
+9,890
+15% +$497K 1.41% 11
2013
Q2
$3.12M Buy
+65,513
New +$3.14M 1.25% 14

Other funds holding XLV

Benjamin F. Edwards & Company's XLV Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its State Street Health Care Select Sector SPDR ETF (XLV) stake by 27% in Q2 2024, buying an estimated $1.05M and bringing the position to 34,464 shares worth $5.02M. The position accounts for 0.09% of the portfolio, ranked #220.

Benjamin F. Edwards & Company first reported a position in XLV in Q2 2013 and has held it in 45 quarters since. The position peaked at $14.3M in Q4 2017. 1,664 funds tracked by Wall St. Rank hold XLV as of Q2 2024.

  • Benjamin F. Edwards & Company held 34,464 shares of State Street Health Care Select Sector SPDR ETF worth $5.02M as of Q2 2024.
  • Benjamin F. Edwards & Company bought 7,342 State Street Health Care Select Sector SPDR ETF shares in Q2 2024, an estimated $1.05M.
  • State Street Health Care Select Sector SPDR ETF made up 0.09% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #220 holding.
  • Benjamin F. Edwards & Company first reported a position in State Street Health Care Select Sector SPDR ETF in Q2 2013 and has held it in 45 quarters since.
  • Benjamin F. Edwards & Company's State Street Health Care Select Sector SPDR ETF position peaked at $14.3M in Q4 2017.
  • 1,664 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.